跳至主要内容
临床试验/NCT02168634
NCT02168634Unknown不适用

The Use of Botulinum Toxin in the Treatment of Itching From Hypertrophic Scar -- A Randomised Controlled Trial

Kaohsiung Veterans General Hospital.1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2013年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
The degree of itchiness

研究概览

简要总结

Hypertrophic scar, a disfiguring tissue reaction to trauma, occurred in around 20 % of the population. The patients with hypertrophic scar usually seek medical assistance not just for the annoying appearance but mostly due to the intractable itchiness. There have been a variety of effective methods to alter the appearance of the scar. However, the treatments for itching from hypertrophic scar are scarce. In 2009, P.Gazerani used Botox to treat histamine-induced itch with favorable results. In the clinical setting, however, the efficacy of Botox to treat itch from hypertrophic scar was yet to be proven. Therefore, the goal of this study is to conduct a randomized controlled trials about using Botox to treat itch from hypertrophic scar.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The patients undergoing laparotomy and thoracotomy in Veterans General Hospital in Kaohsiung (VGHKS) during 2003/1/1~2012/12/31
  • Hypertrophic scars containing more than two itchy sites with itchiness scale >3
  • Good wound healing condition, no infection sign
  • Age older than 20 year-old

排除标准

  • Allergy to Botulinum toxin
  • Inability to express self-willingness

研究组 & 干预措施

Botulinum toxin

Experimental

5U Botulinum toxin in 1cc normal saline, administered in one of the two itchy points

干预措施: Botulinum Toxins (Drug)

Normal Saline

Placebo Comparator

1cc normal saline, administered in the other itchy point

干预措施: Placebo (Drug)

结局指标

主要结局

The degree of itchiness

时间窗: 6 months

次要结局

  • Pain scale(Within one minue after drug injection)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kuei-Chang Hsu

Attending Physician

Kaohsiung Veterans General Hospital.

研究点 (1)

Loading locations...

相似试验